Polar Capital Holdings Plc 13D and 13G filings for Spyre Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 09:39 am Purchase | 2023-12-31 | 13G | SPYRE THERAPEUTICS, INC SYRE | Polar Capital Holdings Plc | 500,000 1.050% | 342,552 (+217.57%) | Filing |